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Abstract Surgical handling of the peritoneum causes an in-
flammatory reaction, during which a potentially lethal cock-
tail of active mediators is produced, including cytokines and
growth factors. The aim of this study was to investigate
the effects of inflammatory cytokines on the interaction be-
tween tumor and mesothelial cells. Tumor cell adhesion to a
mesothelial monolayer was assessed after preincubation of
the mesothelium with interleukin (IL)-1β, IL-6, and tumor
necrosis factor (TNF)-α.
Preincubation of the mesothelial monolayer with IL-1β or
TNF-α resulted in enhanced tumor cell adhesion of Caco2
and HT29 colon carcinoma cells. The amount of stimula-
tion for the Caco2 cells was between 20% and 40% and for
HT29 cells between 30% and 70%. Blocking experiments
with anti–IL-1β and anti–TNF-α resulted in significant in-
hibition of the cytokine-stimulated tumor cell adhesion. The
presented results prove that IL-1β and TNF-α are significant
stimulating factors in tumor cell adhesion in vitro and may
therefore account for tumor recurrence to the peritoneum in
vivo.
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Colorectal cancer accounts for over half of the cases of
gastrointestinal malignancy. Several new adjuvant treatment
modalities improved the overall 5-year survival rate for col-
orectal carcinomas in the last decade. The most recent 5-year
survival rates are, according to a study from France, 36.1%
for local recurrence and 24% for distant metastases [1]. In
the United States, 80% of patients with colorectal cancer
present with local or locally advanced disease and for this
group curative surgery can be attempted. However, up to
40% of these patients develop recurrent disease [2]. Despite
adjuvant chemotherapy, locoregional and distant recurrence
remain a major problem with colorectal cancer. The most
common site for colorectal adenocarcinoma to recur is the
site of the primary tumor; the second is the peritoneal surface
[3]. Therefore, elimination of locoregional recurrence in the
peritoneal cavity may be benefit a significant proportion of
patients in terms of survival or quality of life. A better un-
derstanding of the pathophysiology of tumor recurrence may
lead to more specific tools to confront the initial process of
implantation.
Despite preoperative precautions, tumor spill and subse-
quent implantation, colonization, and growth of these cells in
the peritoneal cavity on either intact or traumatized mesothe-
lium and extracellular matrix is an important mechanism
accounting for tumor recurrence. Wound healing after surgi-
cal trauma induces an inflammatory response during which
high amounts of cytokines and growth factors are produced
[4–6]. These inflammatory mediators are known to upregu-
late adhesion molecules and therefore offer an exceptional
environment for the tumor cells to adhere [7–9].
The aim of this study was to elucidate the role of cytokines
with regard to influencing seeding and colonization of tumor
cells to the surgically traumatized peritoneal surface. There-
fore, we developed an in vitro model to investigate the role
of several major inflammatory cytokines, namely, interleukin
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(IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, on the in-
teraction between human mesothelial cells (MC) and colon
carcinoma cells. We studied the adhesion of Caco2 and HT29
cells on omental-derived MC. Furthermore, we studied the
expression of adhesion molecules and counterparts on the
cells used in this study by immunohistochemistry to deter-
mine the potential interaction sites between the cells.
Materials and methods
Culture and identification of omental mesothelial cells
MC were obtained from the omental tissue of patients under-
going elective abdominal surgery. All patients gave informed
consent. The MC were isolated according to techniques mod-
ified from Nicholson et al [10] and Wu et al [11]. The
omentum was transferred to fluid containing 0.05% trypsin-
0.02% EDTA (Invitrogen, Karlsruhe, Germany). After 15
minutes, the detached MC were pelleted by centrifugation at
450 g for 10 minutes and were resuspended in RPMI 1640
supplemented with 10% fetal calf serum (FCS), l-glutamin
(200 mmol/L), and penicillin (5000 U/mL; Invitrogen). MC
were grown to confluence in a 37◦C, fully humidified, 5%
CO2 cabinet in polystyrene culture flasks (75 cm2; Corning,
Schiphol-Rijk, The Netherlands), precoated with collagen
type I (17.5 µg/cm2). The identity of MC was demonstrated
by the absence of von Willebrand factor staining [12] and
the presence of intracellular cytokeratins [13] via immuno-
histologic staining with monoclonal antibodies (Dako, Am-
sterdam, The Netherlands).
Tumor cell line
The human colon adenocarcinoma Caco-2 and HT29 were
kind gifts of Dr W. Dinjens and are both mucinous adeno-
carcinoma. Both cell lines were cultured in RPMI medium
supplemented with 10% FCS, l-glutamin (200 mmol/L),
and penicillin (5000 U/mL). All supplements were obtained
from Invitrogen. Before use, cells were trypsinized (5 min-
utes at 37◦C), centrifuged (5 minutes at 400 g), resuspended
in RPMI, and counted. Viability was measured by trypan
blue exclusion and always exceeded 95%.
Cytokine preincubation
IL-1β, IL-6, and TNF-α were obtained from R&D Systems
(Uithoorn, The Netherlands). Preincubation of the mesothe-
lial monolayer and tumor cells was performed using increas-
ing concentrations of these mediators.
Anti-human IL-1β and anti-human TNF-α were obtained
from R&D Systems. To inactivate IL-β, preincubation was
performed with a hundredfold excess of anti–IL-1β for 1
hour at 37◦C according to the instructions of the manu-
facturer. After this, the formed IL-1β/anti–IL-1β complex
was added to the mesothelial monolayer for preincubation.
Inactivation of TNF-α was performed in the same way as
inactivation of IL-1β.
Calcein-AM solution and incubation
The dye solution, calcein-AM, used to quantify tumor
cell adhesion was prepared by dissolving 50 µg calcein
(Molecular Probes, Leiden, The Netherlands) in 5 µL an-
hydrous dimethyl sulphoxide (Sigma-Aldrich, Zwijndrecht,
The Netherlands) and adding this solution to 5 mL of
RPMI 1640 medium supplemented with 0.5% bovine serum
albumin (BSA; RPMI 1640/0.5% BSA; Sigma-Aldrich).
Trypsinized Caco2 and HT29 cells (1 × 106 cells/mL) were
incubated in RPMI1640/0.5% BSA at 37◦C for 30 minutes
with occasional mixing.
Adhesion assay
To quantify tumor cell adhesion to a monolayer mesothelium,
a standardized cell adhesion assay was developed accord-
ing to methods of Catterall et al [14]. Mesothelial mono-
layers were established in 96-well plates (Canberra Pack-
erd, Groningen, The Netherlands), precoated with collagen
type I (15 µg/cm2, coating according to instructions of the
manufacturer). To do this, confluent cells were washed with
phosphate-buffered saline (PBS) and harvested with trypsin,
(0.05%), EDTA (0.02%), and 2.5 × 104 MC were added to
200 µL of medium to each well. The plates were incubated
at 37◦C, in a humidified atmosphere of 5% CO2 in air; the
medium was replaced daily with fresh medium. Monolay-
ers reached confluence in 5–7 days as determined by light
microscopy. To determine the effect of the inflammatory
cytokines on tumor cell adhesion, mesothelial monolayers
were preincubated with increasing doses. Non-preincubated
mesothelial monolayers served as controls.
Tumor cells were labeled with calcein as described. Be-
fore addition to the mesothelial monolayers, the labeled cells
were washed twice with RPMI1640/0.5% BSA to remove
any free dye.
Medium from the experimental wells was removed and
200 µL RPMI1640/0.5% BSA containing 30,000 calcein-
labeled tumor cells was added. Plates were centrifuged for 1
minute at 80 g on a Perkin Elmer centrifuge and incubated at
37◦C for 60 minutes. After this, the medium of each well was
removed and washed twice with 200 µL RPMI1640/0.5%
BSA medium. The remaining fluorescence per well was mea-
sured on a Perkin Elmer plate reader using 485 excitation and
530 emission filters. On each plate, a standard was prepared
by adding different numbers of labeled tumor cells to the
wells. The number of tumor cells adhered was determined
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by calibrating the measured fluorescence of the experimental
wells on the standard.
DNA assay
To investigate whether overnight incubation of the mesothe-
lial monolayer with the different cytokines was influencing
the cell growth, a DNA measurement was performed. In
this assay, the DNA content of the MC was measured us-
ing the bisbenzimide fluorescent dye (Roche Diagnostics,
Mannheim, Germany) as previously described by Hofland
et al [15]. In short, at the end of the incubation period the
plates were washed twice with saline and stored at − 20◦C
until further analysis. The cells were extracted with ammonia
solution (1 mmol/L) Triton × 100 (0.2% v/v) by sonification
for 5 seconds at amplitude 15 (Soniprep 150; MSE). There-
after, assay buffer (100 mmol/L NaCl, 10 mmol/L EDTA,
10 mmol/L Tris; pH 7.0) was added. The remaining solu-
tion was centrifuged at 2000 g for 5 minutes and 100-µL
aliquots of the supernatant was mixed with 2 mL Hoechst
dye H33258 (100 µg/L). Fluorescence was measured after
10 minutes with the excitation and emission wavelengths set
at 350 and 455 nm, respectively. The fluorescence of exper-
imental samples were referenced to a standard curve of calf
thymus DNA (type II; Sigma).
Growth curves
The effect of cytokines on tumor cell growth was investi-
gated by incubating the tumor cell lines with 10 ng/ml IL-1β,
IL-6, or TNF-α overnight. Preincubation was initiated im-
mediately after seeding of the tumor cells in 24-well plates.
Growth response to IL-1β, IL-6, and TNF-α (R&D Systems)
was studied at the indicated time points.
Expression of cytokine receptors and adhesion molecules
MC and the colon carcinoma cell lines were prepared
for staining by cytospin preparation, fixed in acetone for
1 minute, and stored at − 20◦C until use. The cytospins
were preincubated for 15 minutes with 10% normal goat
serum, diluted in PBS, and incubated overnight at 4◦C with
goat anti-human monoclonal antibodies to IL-1Ra, IL-6R,
TNF-RI, TNF-RII, ICAM-1, VCAM-1, CD44, LFA-1, and
VLA-4 (all obtained from R&D Systems).
Statistical analysis
All data were analyzed using ANOVA to determine overall
differences between group means. If the ANOVA was sig-
nificant on a 5% level, the post hoc Newman–Keuls test was
carried out to make a comparison between groups. P ≤ .05
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Fig. 1 Tumor cell adhesion of
Caco2 (a) and HT29 (b) to a
mesothelial monolayer after
preincubation of the monolayer
with 0.5, 1, 5, 10, 50, or
100 ng/mL cytokine. Open bars
represent IL-1β pretreated
monolayers, closed bars the
effect of IL-6 pretreated
monolayers, and blocked bars
the effect of TNF-α. Values are
the mean (n = 6) + SEM
∗P < .01
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Fig. 2 Tumor cell adhesion of Caco2 (A/C) and HT29 (B/D) to a
mesothelial monolayer after preincubation of the monolayer with 1, 5,
or 10 ng/mL IL-1β (open bars, (a) and (b)) or TNF-α (open bars, (c)
and (d). The closed bars represent the additional blocking with anti–IL-
1β (A/B) or anti–TNF-α (C/D). Values are the mean (n = 6) + SEM.
∗P < .01
was considered statistically significant. Experiments were
carried out at least twice with comparable results.
Results
Validation of assay
Loading of the tumor cells with calcein did not affect their vi-
ability ( >95% using trypan blue). To determine the stability
of calcein uptake, the release of fluorescence in the super-
natant of labeled cells after an incubation time of up to 120
minutes was measured. The fluorescence of the washed cells
stayed constant for at least 90 minutes, indicating retention
of the dye in the cells (data not shown). A dilution series was
made by using labeled Caco2 and HT29 cells on a mesothe-
lial monolayer. There was a direct relationship between the
cell number added and measured fluorescence, resulting in a
linear correlation that was used as a standard to calibrate the
measured fluorescence. In this way, the amount of adhered
tumor cells in the experimental wells could be determined.
Tumor cell adhesion to a mesothelial monolayer
Tumor cell adhesion to a non-preincubated mesothelial
monolayer was relatively slow and temperature dependent.
Maximum adhesion was seen after 60 minutes. At this time
point, a steady state was achieved and cell adhesion did not
increase thereafter. Tumor cells remained rounded up during
these adhesion assays. After >60 minutes, the first signs of
spreading out could be detected under the light microscope.
Therefore, for all subsequent experiments, 60 minutes was
taken as a cutoff point. Nonstimulated cell adhesion was al-
ways between 25% and 50% of the total amount of tumor
cells added.
Table 1 Tumor cell adhesion to a mesothelial mono-
layer after preincubation of the tumor cells with cytokines
(5 ng/mL)
Control IL-1β TNF-α IL-6
% Adhesion Caco2 45 ± 2 47 ± 3 35 ± 3 41 ± 4
% Adhesion HT29 29 ± 2 31 ± 3 26 ± 4 33 ± 2
Value are the mean of n = 6 ± SD.
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Fig. 3 The effect of IL-1β (open bars), IL-6 (closed bars), and TNF-α
(blocked bars) on the proliferation of a mesothelial monolayer. Data
are expressed as the mean (n = 6) ± SEM. Preincubation did not sig-
nificantly modify total DNA of the monolayer
Effect of cytokine preincubation
Preincubation of the mesothelial monolayer with IL-1β or
TNF-α resulted in enhanced tumor cell adhesion of the
Caco2 and HT29 cells. This effect was dose dependent.
Maximum stimulation was achieved at 5 ng/mL (P < .01).
The amount of stimulation for the Caco2 cells was between
20% and 40% versus the control situation and for HT29
cells between 30% and 70%. Contrary to IL-1β and TNF-α,
IL-6 (1–100 ng/mL) did not alter tumor cell adhesion to a
mesothelial monolayer (Fig.1). After blocking with anti–IL-
1β, stimulation with 1, 5, and 10 ng/mL IL-1β (0.1, 0.5, and
1.0 µg/mL anti–IL-1β) was completely inhibited (Fig. 2).
Blocking with a hundredfold excess of anti–TNF-α in-
hibited the stimulatory effect of TNF-α as well (Fig. 2).
Preincubation of the tumor cells with IL-1β, TNF-α, or IL-6
did not result in a significant increase of adhered tumor cells
to the mesothelial monolayers (Table 1).
DNA assay
Overnight preincubation of a mesothelial monolayer with
IL-1β, IL-6, or TNF-α did not modify total DNA content
of the mesothelial monolayer and therefore did not affect
cell growth (Fig. 3). To investigate the influence of these
cytokines on growing tumor cells, we measured the total
DNA after 2 and 4 days of incubation of the tumor cells
with IL-1β, IL-6, or TNF-α (10 ng/mL). The growth of
Caco2 and HT29 cells was inhibited after 4 days when the
cells were grown in RPMI 1640 10% FCS enriched with
TNF-α or IL-6 (10 ng/mL). IL-1β (10 ng/mL) incubation of
Caco2 and HT29 cells resulted in a minor growth inhibition
(Fig. 4). These results prove the functionality of the cytokine
receptors on the tumor cells.
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Fig. 4 Growth rate of 20,000 Caco2 (a) and HT29 (b) cells incubated
with cytokines IL-1β, IL-6, and TNF-α (10 ng/mL) for 4 days
Expression of cytokine receptors and adhesion molecules
The results of the staining of MC are shown in Fig. 5 and
clearly demonstrate that these cells express receptors for
IL-1β, IL-6, and TNF-α. Table 2 shows the results of the
immunohistochemical staining of the MC and colon car-
cinoma cancer cell lines with the adhesion molecules and
counterparts. The MC stained positive for ICAM-1, VCAM-
1, and CD44. HT29 and Caco2 cell lines are both positive for
ICAM-1, VCAM-1, CD44, LFA-1, and VLA-4. The nega-
tive controls, the positively stained MC, and the counterparts
on the colon carcinoma cell lines are shown in Fig. 6.
Discussion
Local recurrence of colorectal cancer is major clinical prob-
lem. Spilled tumor cells are preferentially distributed to the
resection site, and combined recurrences to the resection site
and peritoneal surfaces are common [3]. The mechanism
behind this process has not been unraveled yet.
After abdominal surgery, there is a reactive inflammatory
response, the acute phase response, during which cytokines
and growth factors are produced [16]. These cytokines are
known to be conducive to wound healing by initiating the
cellular cascade in the course of which macrophages and
leukocytes migrate to the injured site [17]. In addition to
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Fig. 5 Expression of cytokine receptors by MC. (a) Negative control. (b) IL-1β receptor. (c) IL-6 receptor. (d) TNF-α receptor
the production of cytokines by inflammatory cells, the MC
can also produce several chemokines during peritoneal in-
jury [4, 6]. In our experiments, we evaluated the effects of
the cytokines IL-1β, Il-6, and TNF-α on the adhesion of
colon carcinoma cells to mesothelial monolayers. IL-1β is
one of the most investigated proinflammatory cytokine; its
concentration in postoperative peritoneal fluid increases sig-
nificantly. Therefore, it may be of great importance in the
peritoneal cavity [18]. IL-6 is an early marker of tissue dam-
age and the production of IL-6 by MC is influenced by IL-1
and TNF-α in a time- and dose-dependent manner [19–21].
TNF-α has a significant function in the abdominal cavity
and might modulate the inflammatory response by inducing
the production of ILs from MC [22, 23]. Postoperative con-
centrations of TNF-α in the peritoneal cavity are increased
compared to IL-1β as well [18].
Our data advocate the enhancement of adhesion of Caco2
and HT29 cells to a mesothelial monolayer after incubation
with IL-1β or TNF-α in a dose-dependent way. This ef-
fect was completely inhibited by blocking with anti–IL-1β
and anti–TNF-α, which underline the specificity of IL-1β
and TNF-α stimulation and the involvement of a specific re-
lated pathway at which enhanced tumor cells adhesion to the
mesothelial monolayer might be induced. Preincubation of
the mesothelial monolayers with the different cytokines used
in this study did not change the total DNA content and there-
fore demonstrate that the increased adhesion of colon carci-
noma cells to the mesothelium is not caused by an enhanced
number of MC. Other investigators demonstrate the same
effect of cytokines on the enhancement of adhesion with
Table 2 Cell adhesion molecules and counterparts ex-
pressed by mesothelial, caco2, and HT29 cells according to
immunohistochemical staining
ICAM-1 VCAM-1 CD 44 LFA-1 VLA-4
Mesothelial + + + − −
Caco2 + + + + +
HT29 + + + + +
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Fig. 6 Expression of cell adhesion molecules and counterparts after immunohistochemical staining of mesothelial, HT29, and Caco-2 cells. (a),
(b), (c) negative control. (d), (e), (f) CD44. (g) ICAM-1. (h), (i) LFA-1. (j) VCAM-1. (k), (l) VLA-4
different tumor cell lines, like gastric tumor cells, melanoma
cells, and ovarian tumor cells [24–27]. IL-1β and TNF-α are
also potent stimulators of adhesion of colon carcinoma cells
to endothelial cells [28].
The bell-shaped curves of cytokine-stimulated adhesion
are most likely caused by the fact that a high concentration
of cytokine may stimulate MC to produce mediators that can
inhibit the stimulation of adhesion [29]. Another explanation
might be the downregulation of cytokine receptors at high
concentrations of the ligand.
Cytokines do not influence the growth of MC in contrast
to their inhibitory effect on the growth of the colon carcinoma
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cell lines. This inhibitory effect demonstrates the function-
ality of the cytokine receptors on the colon carcinoma cell
lines. Other studies have shown this suppressive effect of IL-
1β and TNF-α on proliferating colon carcinoma cell lines as
well [30–32]. The inhibition of IL-6 on colon carcinoma cell
growth has not been studied previously.
The enhancement of adhesion in this study is most likely
originated by an upregulation of adhesion molecules. Ac-
cording to our immunohistochemical results, MC express
ICAM-1, VCAM-1, and CD44. Caco2 and HT29 cells ex-
press, adjacent to the molecules expressed by the MC, the
counterparts LFA-1 and VLA-4. These results suggest abun-
dant possibilities for cell–cell and cell–matrix interactions
under nonstimulated conditions. The expression patterns are
similar to those observed in the literature. Several studies in-
vestigated the influence of TNF-α and IL-1β on the expres-
sion of adhesion molecules on MC. ICAM-1 and VCAM-1
expression is upregulated by these cytokines, which mani-
fest the importance of these molecules in the interaction with
colon carcinoma cells after stimulation of the mesothelium
with IL-1β and TNF-α [7, 8].
After stimulation of the colon carcinoma cell lines with
the inflammatory cytokines, there was no remarkable en-
hancement of the adhesion to the mesothelial monolayer,
suggesting that the mesothelial monolayer is the primary
cell involved in increased adhesion induced by inflamma-
tory cytokines. Expression of ICAM-1 on HT-29 and Caco2
cells is upregulated by TNF-α and IL-β; however, MC do
not express their counterpart, LFA-1, which might be the ex-
planation for the fact that there was not an enhancement of
adhesion after stimulation of the colon carcinoma cell lines
with the cytokines used in this study [33, 34].
In conclusion, inflammatory cytokines released following
surgical wounding can cause an environment beneficial to
tumor cell adhesion and possibly increases the metastatic
potential of local tumor cells. This study demonstrates that
the enhancement of colon carcinoma cells to a monolayer
mesothelium is induced by IL-β and TNF-α. This enhance-
ment might be derived from an upregulation of ICAM-1,
VCAM-1, and CD44 on MC. Future experiments should de-
termine which of the cell–cell and cell–matrix interactions
are most important in tumor cell adhesion to develop site-
specific drug delivery systems and in that way block the
tumor cells to adhere.
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